Myfembree (relugolix, estradiol, and norethindrone acetate)

pCPA File Number: 23252

Negotiation Status:

Under consideration for negotiation

Indication(s):

Management of heavy menstrual bleeding associated with uterine fibroids

Sponsor/Manufacturer:

Knight Therapeutics Inc.

CDA-AMC Project Number:

SR0885-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable